Genetic Networks

Genetic Networks, founded in 2015, has been at the forefront of serving three of the top ten biopharmaceutical companies with its GeneScape™ technology. GeneScape accelerates drug asset development through molecular biology, providing multidimensional maps of diseases and drugs by integrating proprietary analyses of drug activity (H-Tech) and human genes and gene variants (Y-Tech) using genome-wide functional assays. Genetic Networks' GeneScape™ platform expedites the discovery and development of optimal candidate compounds in preclinical and clinical trials by identifying the best intersections between targets and compounds in specific disease areas through genome-wide genetic perturbation and analysis.